C. Efrata T. R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US. JAI [Internet]. 2016Feb.11 [cited 2025Oct.1];9(1):1-21. Available from: https://journal.umy.ac.id/index.php/ai/article/view/1083